Transcatheter Aortic Valve Implantation (TAVI)
Real-world results
The CoreValve™/Evolut™ platform provides reproducible results from clinical trial to the real world.
This multicenter, prospective, single-arm, observational post-market study evaluated the safety and performance of the Evolut™ R system in a routine hospital setting.
1 year hemodynamic data
30-day procedural outcomes
ADVANCE is a multicenter, prospective, single-arm, observational study to evaluate safety and performance of the CoreValve™ system in a routine clinical setting.
Study Status/Duration: 5-year outcomes reported/5-year follow-up
Sample Size: N = 1,015
Devices: CoreValve, TAV
Review the latest data supporting the Evolut™ platform.
Discover our procedural guidance and outcomes you can expect from the Evolut™ platform.
Medtronic Academy offers a wide range of resources for the Evolut™ TAVI platform.
™* Third-party brands are trademarks of their respective owners.
We do not review or control the content of external sites and are not responsible for any interactions or transactions that may occur there. Any product availability and regulatory requirements on the destination site may differ depending on your location. When you continue, the terms of use and privacy statement of the external site will apply.
Product availability and regulatory requirements may differ depending on your location. The destination website is governed by the laws and regulations of the country in which it operates, which may be different from those in your country. When you continue, the terms of use and privacy statement of the destination Medtronic site will apply.